Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Frontini

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
The International Journal of Biological Markers|April 19, 2005
The favorable prognostic significance of surgery-induced hyperprolactinemia in node-positive breast cancer patients: ten-year disease-free survival resultsA Bignami, P Lissoni, F Brivio, et al.
Tumori|March 18, 1999
Phase II study of the activity and tolerability of a combined regimen of high-dose epirubicin and cisplatin in stage IIIb and IV non-small cell lung cancerM Clerici, F De Marinis, E Piazza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: a high-activity, dose-dense weekly regimen for advanced breast cancerC Nisticò, C Garufi, S Barni, et al.
Cancer|May 15, 1995
Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric studyM Maltoni, M Pirovano, E Scarpi, et al.
Anticancer Research|August 17, 2005
A phase II study of tamoxifen in hormone-resistant metastatic prostate cancer: possible relation with prolactin secretionP Lissoni, P Vigano, M Vaghi, et al.
The International Journal of Biological Markers|July 17, 2004
Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumorsP Lissoni, F Brivio, L Fumagalli, et al.
British Journal of Cancer|February 24, 2001
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancerS Cascinu, F Graziano, S Barni, et al.
British Journal of Cancer|February 23, 1999
Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, L Frontini, G Comella, et al.
Oncology|January 1, 1993
Cisplatin plus epirubicin and etoposide followed by irradiation plus lonidamine in stage III nonsmall cell lung cancerV Filipazzi, M T Cattaneo, B Rho, et al.
Tumori|July 30, 1999
[Adjuvant therapy of colon cancer. State of the art and future perspectives]S Barni, S Cascinu, P Foa, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
The International Journal of Biological Markers|April 19, 2005
The favorable prognostic significance of surgery-induced hyperprolactinemia in node-positive breast cancer patients: ten-year disease-free survival resultsA Bignami, P Lissoni, F Brivio, et al.
Tumori|March 18, 1999
Phase II study of the activity and tolerability of a combined regimen of high-dose epirubicin and cisplatin in stage IIIb and IV non-small cell lung cancerM Clerici, F De Marinis, E Piazza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: a high-activity, dose-dense weekly regimen for advanced breast cancerC Nisticò, C Garufi, S Barni, et al.
Cancer|May 15, 1995
Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric studyM Maltoni, M Pirovano, E Scarpi, et al.
Anticancer Research|August 17, 2005
A phase II study of tamoxifen in hormone-resistant metastatic prostate cancer: possible relation with prolactin secretionP Lissoni, P Vigano, M Vaghi, et al.
The International Journal of Biological Markers|July 17, 2004
Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumorsP Lissoni, F Brivio, L Fumagalli, et al.
British Journal of Cancer|February 24, 2001
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancerS Cascinu, F Graziano, S Barni, et al.
British Journal of Cancer|February 23, 1999
Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, L Frontini, G Comella, et al.
Oncology|January 1, 1993
Cisplatin plus epirubicin and etoposide followed by irradiation plus lonidamine in stage III nonsmall cell lung cancerV Filipazzi, M T Cattaneo, B Rho, et al.
Tumori|July 30, 1999
[Adjuvant therapy of colon cancer. State of the art and future perspectives]S Barni, S Cascinu, P Foa, et al.
Pageof 7